UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson's Disease Journal article
Pharmaceutics, 2022,Volume: 14,Issue: 8,Page: 1731
Authors:  Wang, Qun;  Ma, Rui;  Liu, Piaoxue;  Cheng, Guowang;  Yang, Qi;  Chen, Xiaojia;  Wu, Zhenfeng;  Yuan, Dongsheng;  Chen, Tongkai
Favorite |  | TC[WOS]:1 TC[Scopus]:0 | Submit date:2022/08/26
Polymeric Nanoparticles  Blood-brain Barrier  Drug Delivery  Pharmacokinetics  Brain Accumulation  Parkinsonian Therapy  
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials Journal article
Nano-Micro Letters, 2022,Volume: 14,Issue: 1,Page: 105
Authors:  Cheng, Guowang;  Liu, Yujing;  Ma, Rui;  Cheng, Guopan;  Guan, Yucheng;  Chen, Xiaojia;  Wu, Zhenfeng;  Chen, Tongkai
Favorite |  | TC[WOS]:3 TC[Scopus]:4 | Submit date:2022/05/13
Biomimetic Drug Delivery  Blood–brain Barrier  Nano-biological Effects  Nasal Delivery  Parkinson’s Disease  
Near-Infrared Radiation-Assisted Drug Delivery Nanoplatform to Realize Blood-Brain Barrier Crossing and Protection for Parkinsonian Therapy Journal article
ACS Applied Materials and Interfaces, 2021,Volume: 13,Issue: 31,Page: 37746-37760
Authors:  Liu, Yao;  Hong, Honghai;  Xue, Jincheng;  Luo, Jingshan;  Liu, Qiao;  Chen, Xiaojia;  Pan, Yue;  Zhou, Jingwei;  Liu, Zeming;  Chen, Tongkai
Favorite |  | TC[WOS]:10 TC[Scopus]:10 | Submit date:2021/12/08
Blood-brain Barrier  Natural Product  Neurodegenerative Disease  Noninvasive Targeted Delivery, Neuronal Mitochondria  
NIR-II-Activated Yolk-Shell Nanostructures as an Intelligent Platform for Parkinsonian Therapy Journal article
ACS Applied Bio Materials, 2020,Volume: 3,Issue: 10,Page: 6876-6887
Authors:  Liu, Yao;  Zhu, Daoming;  Luo, Jingshan;  Chen, Xiaojia;  Gao, Liqian;  Liu, Wei;  Chen, Tongkai
Favorite |  | TC[WOS]:10 TC[Scopus]:10 | Submit date:2021/03/02
Blood-brain Barrier  Brain Drug Delivery  Gold Nanorods  Mesoporous Silica  Neurodegenerative Disorders  Nir-ii Biowindow  
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B Journal article
NEUROPHARMACOLOGY, 2017,Volume: 126,Page: 12-24
Authors:  Guo, Baojian;  Hu, Shengquan;  Zheng, Chengyou;  Wang, Hongyu;  Luo, Fangcheng;  Li, Haitao;  Cui, Wei;  Yang, Xifei;  Cui, Guozhen;  Mak, Shinghung;  Choi, Tony Chung-Lit;  Ma, Edmond Dik-Lung;  Wang, Yuqiang;  Lee, Simon Ming Yuen;  Zhang, Zaijun;  Han, Yifan
View | Adobe PDF | Favorite |  | TC[WOS]:16 TC[Scopus]:18 | Submit date:2018/10/31
Parkinson's Disease  Su4312  Neuroprotection  Myocyte Enhancer Factor 2d  Monoamine Oxidase-b  
Recapitulating and correcting marfan syndrome in a cellular model Journal article
International Journal of Biological Sciences, 2017,Volume: 13,Issue: 5,Page: 588-603
Authors:  Park J.W.;  Yan L.;  Stoddard C.;  Wang X.;  Yue Z.;  Crandall L.;  Robinson T.;  Chang Y.;  Denton K.;  Li E.;  Jiang B.;  Zhang Z.;  Martins-Taylor K.;  Yee S.-P.;  Nie H.;  Gu F.;  Si W.;  Xie T.;  Yue L.;  Xu R.-H.
Adobe PDF | Favorite |  | TC[WOS]:13 TC[Scopus]:13 | Submit date:2018/12/20
Disease Modeling  Genome Editing  Human Pluripotent Stem Cells  Marfan Syndrome  Osteogenesis  Smooth Muscle